eScholarship
metadata only
UC Comments in Response to FDA's Proposed Guidance for Sponsors, Investigators,and Institutional Review Boards on Key Information and Facilitating Understanding in Informed Consent (Docket Number: FDA-2022-D-2997)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- E-Cigarettes and the Multiple Responsibilities of the FDA#771770
- UC Comments on Docket No. FDA-2021-N-0286 for “Protection of Human Subjects and Institutional Review Boards” (September 28, 2022)#629312
- Performance of a large language model in the informed consent process for participation in a clinical trial.#1098045
- Research participants’ perceptions and views on consent for biobank research: a review of empirical data and ethical analysis#716642
- WHO Drug Information 2025, vol. 39, 1 [full issue]#166326
Record · ID 629288
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive